| Revolution Medicines, Inc. | 1.5M | US$281M | 11.1% |
| Insmed Incorporated | 1.6M | US$171M | 6.7% |
| Cytokinetics, Incorporated | 1.6M | US$136M | 5.4% |
| Cvs Health Corporation | 1.1M | US$114M | 4.5% |
| Edgewise Therapeutics, Inc. | 2M | US$81.3M | 3.2% |
| Vera Therapeutics, Inc. | 1.75M | US$75.1M | 3.0% |
| Axsome Therapeutics, Inc. | 300K | US$73.4M | 2.9% |
| Cardinal Health, Inc. | 300K | US$71.3M | 2.8% |
| Roivant Sciences Ltd. | 2M | US$70.8M | 2.8% |
| Rhythm Pharmaceuticals, Inc. | 550K | US$61.1M | 2.4% |
| Edwards Lifesciences Corporation | 625K | US$56.5M | 2.2% |
| Alignment Healthcare, Inc. | 2M | US$47.6M | 1.9% |
| Merck & Company, Inc. | 350K | US$45M | 1.8% |
| Quest Diagnostics Incorporated | 200K | US$42.4M | 1.7% |
| Scholar Rock Holding Corporation | 750K | US$41.3M | 1.6% |
| Boston Scientific Corporation | 900K | US$38.4M | 1.5% |
| Brightspring Health Services, Inc. | 550K | US$38.4M | 1.5% |
| Abbott Laboratories | 400K | US$36.3M | 1.4% |
| Unitedhealth Group Incorporated | 85,000 | US$35.3M | 1.4% |
| Lifestance Health Group, Inc. | 3M | US$32.1M | 1.3% |
| Novartis Ag | 200K | US$31.3M | 1.2% |
| Tango Therapeutics, Inc. | 1M | US$31.3M | 1.2% |
| Tenet Healthcare Corporation | 165K | US$30.9M | 1.2% |
| Spyre Therapeutics, Inc. | 325K | US$28.9M | 1.1% |
| Novo Nordisk A/s Class B | 600K | US$28.8M | 1.1% |
| Definium Therapeutics, Inc. | 550K | US$25.9M | 1.0% |
| Neurocrine Biosciences, Inc. | 150K | US$25.3M | 1.00% |
| Regeneron Pharmaceuticals, Inc. | 40,000 | US$24.9M | 0.99% |
| Biogen Inc. | 100K | US$21.6M | 0.85% |
| Travere Therapeutics, Inc. | 375K | US$21.3M | 0.84% |
| Lantheus Holdings, Inc. | 190K | US$21.1M | 0.83% |
| Glaukos Corporation | 150K | US$21M | 0.83% |
| Oric Pharmaceuticals, Inc. | 1.9M | US$20.6M | 0.81% |
| Bridgebio Pharma, Inc. | 275K | US$20.5M | 0.81% |
| Vertex Pharmaceuticals Incorporated | 40,000 | US$19.9M | 0.78% |
| Alumis Inc. | 700K | US$19.7M | 0.78% |
| Elevance Health, Inc. | 50,000 | US$19.3M | 0.76% |
| Centene Corporation | 300K | US$19.3M | 0.76% |
| Erasca, Inc. | 1M | US$18.3M | 0.72% |
| Eli Lilly And Company | 15,000 | US$18M | 0.71% |
| Arrowhead Pharmaceuticals, Inc. | 200K | US$16.3M | 0.64% |
| Envista Holdings Corporation | 600K | US$15.8M | 0.62% |
| Waters Corporation | 40,000 | US$15M | 0.59% |
| Forte Biosciences, Inc. | 675K | US$14.3M | 0.57% |
| Madrigal Pharmaceuticals, Inc. | 25,000 | US$13.4M | 0.53% |
| Praxis Precision Medicines, Inc. | 40,000 | US$13.4M | 0.53% |
| Alto Neuroscience, Inc. | 500K | US$13.2M | 0.52% |
| Mineralys Therapeutics, Inc. | 450K | US$12.1M | 0.48% |
| Xenon Pharmaceuticals Inc. | 200K | US$12.1M | 0.48% |
| Acadia Healthcare Company, Inc. | 400K | US$11.8M | 0.47% |
| Irhythm Holdings, Inc. | 90,000 | US$10.7M | 0.42% |
| Biohaven Ltd. | 700K | US$10.4M | 0.41% |
| Beam Therapeutics Inc. | 300K | US$10.3M | 0.41% |
| Integra Lifesciences Holdings Corporation | 550K | US$9.88M | 0.39% |
| Ge Healthcare Technologies Inc. | 150K | US$9.6M | 0.38% |
| Regenxbio Inc. | 800K | US$9.58M | 0.38% |
| Absci Corporation | 800K | US$9.27M | 0.37% |
| Bruker Corporation | 150K | US$9.03M | 0.36% |
| Cencora, Inc. | 30,000 | US$8.49M | 0.34% |
| Cogent Biosciences, Inc. | 200K | US$7.74M | 0.31% |
| Enliven Therapeutics, Inc. | 150K | US$7.61M | 0.30% |
| Bioage Labs, Inc. | 300K | US$7.35M | 0.29% |
| Sana Biotechnology, Inc. | 2M | US$6.98M | 0.28% |
| Inventiva Sa | 1.52M | US$5.75M | 0.23% |
| Protara Therapeutics, Inc. | 1.5M | US$5.73M | 0.23% |
| Lb Pharmaceuticals Inc | 150K | US$4.87M | 0.19% |
| Kardigan, Inc. | 200K | US$4.77M | 0.19% |
| Inspire Medical Systems, Inc. | 100K | US$4.46M | 0.18% |
| Trevi Therapeutics, Inc. | 200K | US$3.73M | 0.15% |
| Ideaya Biosciences, Inc. | 100K | US$3.73M | 0.15% |
| Celldex Therapeutics, Inc. | 100K | US$3.72M | 0.15% |
| Savara, Inc. | 600K | US$3.7M | 0.15% |
| Relmada Therapeutics, Inc. | 500K | US$3.46M | 0.14% |
| Mobia Medical, Inc. | 250K | US$3.35M | 0.13% |
| Sionna Therapeutics, Inc. | 75,000 | US$3.3M | 0.13% |
| Veradermics, Incorporated | 25,000 | US$3.07M | 0.12% |
| Inhibikase Therapeutics, Inc. | 1.35M | US$2.74M | 0.11% |
| Rezolute, Inc. | 500K | US$2.6M | 0.10% |
| Denali Therapeutics Inc. | 100K | US$2.57M | 0.10% |
| Tenax Therapeutics, Inc. | 167K | US$2.43M | 0.10% |
| Olema Pharmaceuticals, Inc. | 100K | US$1.25M | 0.05% |
| Aura Biosciences, Inc. | 170K | US$1.21M | 0.05% |
| Elanco Animal Health Incorporated | 0 | US$0 | 0.00% |
| Evommune, Inc. | 0 | US$0 | 0.00% |
| Fresenius Medical Care Ag | 0 | US$0 | 0.00% |
| Gilead Sciences, Inc. | 0 | US$0 | 0.00% |
| Intuitive Surgical, Inc. | 0 | US$0 | 0.00% |
| Ionis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Iqvia Holdings, Inc. | 0 | US$0 | 0.00% |
| Maze Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Nurix Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Protagonist Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Syndax Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Tarsus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Thermo Fisher Scientific Inc | 0 | US$0 | 0.00% |
| Unicycive Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Viking Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Zimmer Biomet Holdings, Inc. | 0 | US$0 | 0.00% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |